𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract

✍ Scribed by Herren Wu; David S. Pfarr; Syd Johnson; Yambasu A. Brewah; Robert M. Woods; Nita K. Patel; Wendy I. White; James F. Young; Peter A. Kiener

Book ID
116663417
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
1023 KB
Volume
368
Category
Article
ISSN
0022-2836

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Respiratory syncytial virus and human rh
Respiratory syncytial virus and human rhinoviruses are the major causes of severe lower respiratory tract infections in Kuwait
✍ M. Khadadah; S. Essa; Z. Higazi; N. Behbehani; W. Al-Nakib πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 1 views

## Abstract Respiratory infections are very common in Kuwait, yet little is known about the cause of severe lower respiratory tract infections. This study was designed to investigate the viral cause of lower respiratory tract infections using sensitive molecular methods. PCR was applied to investig